GRAL GRAIL, LLC
Company Analysis
Latest News
🔴 GRAIL is trading 4.1% down today on securities-fraud class action reminders
GRAIL is trading 4.1% down at $72.71 following fresh securities-fraud class action reminders tied to the company's failed NHS-Galleri cancer trial in...
🟢 GRAIL is trading 5.5% up today as class-action deadlines loom following February trial failure
GRAIL is trading 5.5% up today at $73.99, attempting to recover from steep losses tied to a failed NHS-Galleri cancer trial and subsequent allegations of...
GRAIL faces fraud lawsuits, following failed NHS-Galleri cancer trial results
Law firms Bleichmar Fonti & Auld LLP and Bronstein, Gewirtz & Grossman, LLC filed a class-action lawsuit against GRAIL, Inc. The suit alleges GRAIL and its...
🔴 GRAL is trading 4.7% down today on fresh coverage of securities fraud litigation over Galleri trial disclosures
GRAL is trading 4.7% down at $65.72 following fresh coverage of a securities fraud class action lawsuit tied to its NHS-Galleri trial disclosures. • The...
🟢 GRAL is trading 4.3% up today with no clear stock-specific catalyst yet
GRAL is trading 4.3% up now at $71.05, rebounding from recent consolidation around the high‑$60s. No fresh company-specific news, filings, or major analyst...